Allotex

medical devices

About

Allotex is an ophthalmic biologics and device company founded in 2014, headquartered in Boston, Massachusetts, with research and development facilities in Zurich, Switzerland. The company focuses on developing innovative therapeutic solutions for vision correction, specifically targeting presbyopia and hyperopia. Their flagship product, the TransForm™ Lenticule, is a precisely-shaped human corneal allograft that acts as a permanent, biocompatible lens insert. This "living contact lens" is designed to restore or improve near and intermediate vision by adding tissue to the cornea. Allotex combines advanced excimer laser technology and optical coherence tomography to ensure the safety and efficacy of their products. The company aims to provide ophthalmologists and eye care professionals with natural, tissue-based alternatives to synthetic implants and laser procedures.

Technologies

Cloudflare DNS Outlook CloudFlare Hosting Remote

Keywords

ophthalmology tissue addition surgery refractive micro-engineering laser vision correction refractive surgery permanent contact lens medical devices medical equipment and supplies manufacturing tissue addition technology clinical validation myopia treatment biologics allograft tissue hyperopia treatment ophthalmic biologics b2c presbyopia treatment vision correction biocompatible lens inserts shelf life extension tissue sculpting biocompatible allografts corneal implants ophthalmic device biotechnology micro-engineered lenses biotech startup corneal shape modification corneal lenticules living tissue implants

Location

27-43 Wormwood St, Boston, Massachusetts, United States, 02210

Related Companies

Companies in the same industry